应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
GKOS Glaukos Corp
休市中 07-11 16:00:00 EDT
103.81
-2.74
-2.57%
盘后
103.81
+0.00
0.00%
16:10 EDT
最高
105.49
最低
103.08
成交量
66.05万
今开
104.98
昨收
106.55
日振幅
2.26%
总市值
59.29亿
流通市值
57.30亿
总股本
5,711万
成交额
6,857万
换手率
1.20%
流通股本
5,519万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Glaukos Corporation涨3.34% 股价突破100美元大关
市场透视 · 06-24
Glaukos Corporation涨3.34% 股价突破100美元大关
Glaukos Corporation跌2.29% 股价跌破100美元大关
市场透视 · 06-20
Glaukos Corporation跌2.29% 股价跌破100美元大关
Glaukos Corporation涨2.64% 股价突破100美元大关
市场透视 · 06-16
Glaukos Corporation涨2.64% 股价突破100美元大关
Glaukos Corporation涨4.60% 股价突破100美元大关
市场透视 · 06-11
Glaukos Corporation涨4.60% 股价突破100美元大关
Glaukos Corporation涨4.30% 股价突破100美元大关
市场透视 · 05-27
Glaukos Corporation涨4.30% 股价突破100美元大关
大摩:维持Glaukos(GKOS.US)评级,由减持调整至减持评级, 目标价由110.00美元调整至72.00美元。
金融界 · 05-06
大摩:维持Glaukos(GKOS.US)评级,由减持调整至减持评级, 目标价由110.00美元调整至72.00美元。
异动解读 | Glaukos股价盘中大涨7.21%,分析师维持"买入"评级
异动解读 · 05-02
异动解读 | Glaukos股价盘中大涨7.21%,分析师维持"买入"评级
Stephens & Co.:维持Glaukos(GKOS.US)评级,由增持调整至增持评级, 目标价由140.00美元调整至115.00美元。
金融界 · 05-02
Stephens & Co.:维持Glaukos(GKOS.US)评级,由增持调整至增持评级, 目标价由140.00美元调整至115.00美元。
Stifel:维持Glaukos(GKOS.US)评级,由买入调整至买入评级, 目标价由140.00美元调整至115.00美元。
金融界 · 05-01
Stifel:维持Glaukos(GKOS.US)评级,由买入调整至买入评级, 目标价由140.00美元调整至115.00美元。
异动解读 | 格劳科斯股价盘中暴跌11.62%,多家投行大幅下调目标价
异动解读 · 05-01
异动解读 | 格劳科斯股价盘中暴跌11.62%,多家投行大幅下调目标价
Glaukos Corporation盘中异动 大幅跳水11.33%
市场透视 · 05-01
Glaukos Corporation盘中异动 大幅跳水11.33%
富国银行:下调Glaukos(GKOS.US)评级,由增持调整至持股观望评级, 目标价由160.00美元调整至86.00美元。
金融界 · 05-01
富国银行:下调Glaukos(GKOS.US)评级,由增持调整至持股观望评级, 目标价由160.00美元调整至86.00美元。
Needham:维持Glaukos(GKOS.US)评级,由买入调整至买入评级, 目标价由176.00美元调整至115.00美元。
金融界 · 05-01
Needham:维持Glaukos(GKOS.US)评级,由买入调整至买入评级, 目标价由176.00美元调整至115.00美元。
异动解读 | Glaukos股价盘前大跌8.74%,分析师大幅下调目标价
异动解读 · 05-01
异动解读 | Glaukos股价盘前大跌8.74%,分析师大幅下调目标价
异动解读 | 格劳科斯股价盘前大跌8.74%,多家券商下调目标价
异动解读 · 05-01
异动解读 | 格劳科斯股价盘前大跌8.74%,多家券商下调目标价
异动解读 | Glaukos股价盘后大跌6.63%,尽管季度业绩优于预期
异动解读 · 04-30
异动解读 | Glaukos股价盘后大跌6.63%,尽管季度业绩优于预期
异动解读 | Glaukos股价盘后大跌6.63%,尽管一季度业绩超预期
异动解读 · 04-30
异动解读 | Glaukos股价盘后大跌6.63%,尽管一季度业绩超预期
Glaukos Corporation盘中异动 早盘急速上涨6.47%报95.54美元
市场透视 · 04-23
Glaukos Corporation盘中异动 早盘急速上涨6.47%报95.54美元
瑞穗银行:维持Glaukos(GKOS.US)评级,由优于大市调整至优于大市评级, 目标价由200.00美元调整至175.00美元。
金融界 · 04-16
瑞穗银行:维持Glaukos(GKOS.US)评级,由优于大市调整至优于大市评级, 目标价由200.00美元调整至175.00美元。
Glaukos Corporation盘中异动 股价大跌5.85%报89.00美元
市场透视 · 04-16
Glaukos Corporation盘中异动 股价大跌5.85%报89.00美元
加载更多
公司概况
公司名称:
Glaukos Corp
所属市场:
NYSE
上市日期:
--
主营业务:
Glaukos Corporation于1998年7月14日在特拉华州注册成立。该公司是一家眼科制药和医疗技术公司,专注于开发新型无滴剂疗法,并将相关产品商业化,用于治疗青光眼、角膜疾病和视网膜疾病。他们首先开发了微创青光眼手术(MIGS)作为传统青光眼治疗模式的替代方案,并于2012年推出了他们的第一台MIGS设备。他们还提供商业化的专有生物激活药物疗法,用于治疗罕见的角膜疾病圆锥角膜,该疗法于2016年获得美国食品和药物管理局(FDA)的批准。他们正在开发一系列平台,以支持正在进行的制药和医疗器械创新。
发行价格:
--
{"stockData":{"symbol":"GKOS","market":"US","secType":"STK","nameCN":"Glaukos Corp","latestPrice":103.81,"timestamp":1752264000000,"preClose":106.55,"halted":0,"volume":660520,"hourTrading":{"tag":"盘后","latestPrice":103.81,"preClose":103.81,"latestTime":"16:10 EDT","volume":14642,"amount":1519986.02,"timestamp":1752264655931},"delay":0,"floatShares":55193042,"shares":57112526,"eps":-2.268556,"marketStatus":"休市中","change":-2.74,"latestTime":"07-11 16:00:00 EDT","open":104.98,"high":105.485,"low":103.08,"amount":68572418.8212,"amplitude":0.022572,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.268556,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1435204800000,"exchange":"NYSE","adjPreClose":106.55,"preHourTrading":{"tag":"盘前","latestPrice":105.2,"preClose":106.59,"latestTime":"09:22 EDT","volume":86,"amount":9049.17972,"timestamp":1752240136207},"postHourTrading":{"tag":"盘后","latestPrice":103.81,"preClose":103.81,"latestTime":"16:10 EDT","volume":14642,"amount":1519986.02,"timestamp":1752264655931},"volumeRatio":1.0354269907885145,"impliedVol":0.5747,"impliedVolPercentile":0.612},"requestUrl":"/m/hq/s/GKOS","defaultTab":"news","newsList":[{"id":"2546258536","title":"Glaukos Corporation涨3.34% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2546258536","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546258536?lang=zh_cn&edition=full","pubTime":"2025-06-25 03:33","pubTimestamp":1750793603,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日03时33分,Glaukos Corporation股票出现异动,股价快速拉升3.34%。截至发稿,该股报100.04美元/股,成交量28.232万股,换手率0.49%,振幅3.29%。Glaukos Corporation股票所在的医疗器械行业中,整体涨幅为2.24%。Glaukos Corporation公司简介:Glaukos Corp是一家眼科制药和医疗技术公司,专注于开发用于青光眼、角膜疾病和视网膜疾病治疗的新型、无滴疗法和商业化相关产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625033324978d40d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625033324978d40d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GKOS","LU1878469433.USD","LU2065731478.USD","IE0009354923.USD","BK4082","BK4548"],"gpt_icon":0},{"id":"2545709191","title":"Glaukos Corporation跌2.29% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2545709191","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545709191?lang=zh_cn&edition=full","pubTime":"2025-06-21 03:47","pubTimestamp":1750448844,"startTime":"0","endTime":"0","summary":"北京时间2025年06月21日03时47分,Glaukos Corporation股票出现异动,股价急速下跌2.29%。截至发稿,该股报100.00美元/股,成交量89.6033万股,换手率1.57%,振幅2.72%。Glaukos Corporation股票所在的医疗器械行业中,整体涨幅为0.12%。Glaukos Corporation公司简介:Glaukos Corp是一家眼科制药和医疗技术公司,专注于开发用于青光眼、角膜疾病和视网膜疾病治疗的新型、无滴疗法和商业化相关产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621034724a7151596&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621034724a7151596&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","IE0009354923.USD","BK4548","GKOS","LU2065731478.USD","LU1878469433.USD"],"gpt_icon":0},{"id":"2543608274","title":"Glaukos Corporation涨2.64% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2543608274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543608274?lang=zh_cn&edition=full","pubTime":"2025-06-16 21:36","pubTimestamp":1750081006,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日21时36分,Glaukos Corporation股票出现波动,股价急速上涨2.64%。截至发稿,该股报100.18美元/股,成交量4.2103万股,换手率0.07%,振幅1.50%。Glaukos Corporation股票所在的医疗器械行业中,整体涨幅为0.34%。Glaukos Corporation公司简介:Glaukos Corp是一家眼科制药和医疗技术公司,专注于开发用于青光眼、角膜疾病和视网膜疾病治疗的新型、无滴疗法和商业化相关产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506162136469781ed99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506162136469781ed99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","IE0009354923.USD","LU2065731478.USD","LU1878469433.USD","BK4548","GKOS"],"gpt_icon":0},{"id":"2542713535","title":"Glaukos Corporation涨4.60% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2542713535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542713535?lang=zh_cn&edition=full","pubTime":"2025-06-11 23:12","pubTimestamp":1749654744,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日23时12分,Glaukos Corporation股票出现波动,股价急速拉升4.60%。截至发稿,该股报100.04美元/股,成交量33.3344万股,换手率0.58%,振幅4.05%。Glaukos Corporation股票所在的医疗器械行业中,整体涨幅为0.04%。Glaukos Corporation公司简介:Glaukos Corp是一家眼科制药和医疗技术公司,专注于开发用于青光眼、角膜疾病和视网膜疾病治疗的新型、无滴疗法和商业化相关产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061123122595180352&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061123122595180352&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GKOS","BK4548","IE0009354923.USD","BK4082","LU2065731478.USD","LU1878469433.USD"],"gpt_icon":0},{"id":"2538467959","title":"Glaukos Corporation涨4.30% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2538467959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538467959?lang=zh_cn&edition=full","pubTime":"2025-05-27 22:06","pubTimestamp":1748354818,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日22时06分,Glaukos Corporation股票出现异动,股价快速拉升4.30%。截至发稿,该股报100.15美元/股,成交量7.5264万股,换手率0.13%,振幅2.50%。Glaukos Corporation股票所在的医疗器械行业中,整体涨幅为1.31%。Glaukos Corporation公司简介:Glaukos Corp是一家眼科制药和医疗技术公司,专注于开发用于青光眼、角膜疾病和视网膜疾病治疗的新型、无滴疗法和商业化相关产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527220659a48e7cb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527220659a48e7cb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BK4548","GKOS","LU1878469433.USD","LU2065731478.USD","IE0009354923.USD"],"gpt_icon":0},{"id":"2533653571","title":"大摩:维持Glaukos(GKOS.US)评级,由减持调整至减持评级, 目标价由110.00美元调整至72.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2533653571","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533653571?lang=zh_cn&edition=full","pubTime":"2025-05-06 22:43","pubTimestamp":1746542637,"startTime":"0","endTime":"0","summary":"大摩:维持Glaukos(GKOS.US)评级,由减持调整至减持评级, 目标价由110.00美元调整至72.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/06224350176366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GKOS"],"gpt_icon":0},{"id":"1161779164","title":"异动解读 | Glaukos股价盘中大涨7.21%,分析师维持\"买入\"评级","url":"https://stock-news.laohu8.com/highlight/detail?id=1161779164","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161779164?lang=zh_cn&edition=full","pubTime":"2025-05-03 03:32","pubTimestamp":1746214358,"startTime":"0","endTime":"0","summary":"周五盘中,眼科医疗技术公司Glaukos Corp股价出现显著上涨,涨幅达7.21%,引起投资者广泛关注。这一涨势可能与Stephens & Co.最新发布的分析报告有关。该机构维持了对Glaukos的\"买入\"评级,尽管将目标价从140.00美元下调至115.00美元。Glaukos Corp是一家专注于开发创新眼科治疗方案的公司,主要针对青光眼、角膜疾病和视网膜疾病。此外,Glaukos还提供多种微创手术器械产品,如iStent、iStent inject W和iStent infinite,进一步巩固了其在眼科医疗器械市场的地位。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Glaukos股价盘中大涨7.21%,分析师维持\"买入\"评级","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GKOS"],"gpt_icon":0},{"id":"2532279268","title":"Stephens & Co.:维持Glaukos(GKOS.US)评级,由增持调整至增持评级, 目标价由140.00美元调整至115.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532279268","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532279268?lang=zh_cn&edition=full","pubTime":"2025-05-03 01:02","pubTimestamp":1746205361,"startTime":"0","endTime":"0","summary":"Stephens & Co.:维持Glaukos(GKOS.US)评级,由增持调整至增持评级, 目标价由140.00美元调整至115.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/03010250110399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GKOS"],"gpt_icon":0},{"id":"2532007701","title":"Stifel:维持Glaukos(GKOS.US)评级,由买入调整至买入评级, 目标价由140.00美元调整至115.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532007701","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532007701?lang=zh_cn&edition=full","pubTime":"2025-05-02 00:11","pubTimestamp":1746115901,"startTime":"0","endTime":"0","summary":"Stifel:维持Glaukos(GKOS.US)评级,由买入调整至买入评级, 目标价由140.00美元调整至115.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/02001150084810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GKOS"],"gpt_icon":0},{"id":"1120239980","title":"异动解读 | 格劳科斯股价盘中暴跌11.62%,多家投行大幅下调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1120239980","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120239980?lang=zh_cn&edition=full","pubTime":"2025-05-01 21:45","pubTimestamp":1746107147,"startTime":"0","endTime":"0","summary":"格劳科斯公司周四盘中股价暴跌11.62%,主要受到多家知名投资银行大幅下调目标价的影响。据最新消息,摩根大通对格劳科斯的目标价做出了最大幅度的调整,将其从此前的160美元大幅下调至100美元,降幅高达37.5%。这些知名投资银行的一致行动引发了投资者对格劳科斯未来前景的担忧,导致其股价在盘中出现大幅下跌。格劳科斯作为一家专注于开发和商业化用于治疗青光眼的创新技术的医疗器械公司,其股价表现一直受到市场密切关注。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GKOS"],"gpt_icon":0},{"id":"2532008223","title":"Glaukos Corporation盘中异动 大幅跳水11.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532008223","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532008223?lang=zh_cn&edition=full","pubTime":"2025-05-01 21:33","pubTimestamp":1746106408,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日21时33分,Glaukos Corporation股票出现波动,股价大幅下跌11.33%。Glaukos Corporation股票所在的医疗器械行业中,整体跌幅为0.88%。其相关个股中,Nanovibronix, Inc.、Conmed Corporation、Tandem Diabetes Care, Inc.涨幅较大,Nanovibronix, Inc.、Bluejay Diagnostics, Inc.、Invo Fertility, Inc.较为活跃,换手率分别为1433.01%、226.08%、80.98%,振幅较大的相关个股有Pulmonx Corporation、Nanovibronix, Inc.、Zimvie Inc.,振幅分别为15.71%、9.93%、8.83%。Glaukos Corporation公司简介:Glaukos Corp是一家眼科制药和医疗技术公司,专注于开发用于青光眼、角膜疾病和视网膜疾病治疗的新型、无滴疗法和商业化相关产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213328a6d011ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213328a6d011ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065731478.USD","LU1878469433.USD","GKOS","IE0009354923.USD","BK4548","BK4082"],"gpt_icon":0},{"id":"2532727270","title":"富国银行:下调Glaukos(GKOS.US)评级,由增持调整至持股观望评级, 目标价由160.00美元调整至86.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532727270","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532727270?lang=zh_cn&edition=full","pubTime":"2025-05-01 20:59","pubTimestamp":1746104359,"startTime":"0","endTime":"0","summary":"富国银行:下调Glaukos(GKOS.US)评级,由增持调整至持股观望评级, 目标价由160.00美元调整至86.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/01205950082917.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GKOS"],"gpt_icon":0},{"id":"2532807956","title":"Needham:维持Glaukos(GKOS.US)评级,由买入调整至买入评级, 目标价由176.00美元调整至115.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532807956","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532807956?lang=zh_cn&edition=full","pubTime":"2025-05-01 19:44","pubTimestamp":1746099899,"startTime":"0","endTime":"0","summary":"Needham:维持Glaukos(GKOS.US)评级,由买入调整至买入评级, 目标价由176.00美元调整至115.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/01194450081279.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GKOS"],"gpt_icon":0},{"id":"1193923136","title":"异动解读 | Glaukos股价盘前大跌8.74%,分析师大幅下调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1193923136","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193923136?lang=zh_cn&edition=full","pubTime":"2025-05-01 19:02","pubTimestamp":1746097367,"startTime":"0","endTime":"0","summary":"Glaukos Corp周四盘前股价大跌8.74%,引起投资者广泛关注。这一显著跌幅似乎与多家知名投资银行下调该公司目标股价有关。根据最新消息,摩根大通大幅下调了Glaukos的目标价,从此前的160美元骤降至100美元,降幅高达37.5%。作为一家专注于开发和商业化用于治疗青光眼的创新技术的医疗器械公司,Glaukos的股价表现一直受到市场密切关注。投资者应密切关注公司接下来的公告和财报,以更好地理解这次股价调整背后的具体原因。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GKOS"],"gpt_icon":0},{"id":"1103631356","title":"异动解读 | 格劳科斯股价盘前大跌8.74%,多家券商下调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1103631356","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103631356?lang=zh_cn&edition=full","pubTime":"2025-05-01 19:02","pubTimestamp":1746097363,"startTime":"0","endTime":"0","summary":"格劳科斯公司周四盘前股价大跌8.74%,主要受到多家券商下调目标价的影响。据悉,摩根大通将格劳科斯的目标价从160美元大幅下调至100美元,降幅高达37.5%。分析人士指出,尽管目前尚不清楚券商下调目标价的具体原因,但这可能反映出他们对格劳科斯公司近期业务表现或行业环境的看法发生了变化。投资者应密切关注公司未来的财报表现和业务发展,以评估这一价格调整是否合理。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 格劳科斯股价盘前大跌8.74%,多家券商下调目标价","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GKOS"],"gpt_icon":0},{"id":"1139147118","title":"异动解读 | Glaukos股价盘后大跌6.63%,尽管季度业绩优于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1139147118","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139147118?lang=zh_cn&edition=full","pubTime":"2025-05-01 05:20","pubTimestamp":1746048053,"startTime":"0","endTime":"0","summary":"医疗设备公司Glaukos Corp在发布第一季度财报后,股价在盘后交易中大跌6.63%。尽管公司的业绩超出了分析师的预期,但投资者似乎对公司的整体表现仍持谨慎态度。根据公司发布的财报,Glaukos在截至3月31日的季度中,调整后每股亏损为0.22美元,优于分析师平均预期的0.35美元亏损。尽管季度业绩优于预期,但投资者似乎更关注公司的长期发展前景。值得注意的是,Glaukos的股价今年以来已下跌37.4%,这可能反映了市场对公司持续亏损的担忧。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GKOS"],"gpt_icon":0},{"id":"1155994913","title":"异动解读 | Glaukos股价盘后大跌6.63%,尽管一季度业绩超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1155994913","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155994913?lang=zh_cn&edition=full","pubTime":"2025-05-01 05:20","pubTimestamp":1746048052,"startTime":"0","endTime":"0","summary":"医疗器械公司Glaukos今日盘后股价大跌6.63%,尽管公司发布的第一季度财报显示业绩超出市场预期。这一意外走势引发了投资者对公司长期盈利能力的担忧。根据Glaukos公布的财报,截至3月31日的第一季度,公司调整后每股亏损为0.22美元,优于分析师预期的0.35美元亏损。值得注意的是,Glaukos股价在过去一个季度已下跌4.7%,今年迄今累计跌幅高达37.4%。这可能是导致公司股价在盘后交易中大幅下跌的主要原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | Glaukos股价盘后大跌6.63%,尽管一季度业绩超预期","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GKOS"],"gpt_icon":0},{"id":"2529682766","title":"Glaukos Corporation盘中异动 早盘急速上涨6.47%报95.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529682766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529682766?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:31","pubTimestamp":1745415102,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时31分,Glaukos Corporation股票出现波动,股价大幅拉升6.47%。截至发稿,该股报95.54美元/股,成交量3279股,换手率0.01%,振幅0.00%。Glaukos Corporation股票所在的医疗器械行业中,整体涨幅为1.82%。Glaukos Corporation公司简介:Glaukos Corp是一家眼科制药和医疗技术公司,专注于开发用于青光眼、角膜疾病和视网膜疾病治疗的新型、无滴疗法和商业化相关产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213142aa2c7808&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213142aa2c7808&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0009354923.USD","BK4082","GKOS","BK4548","LU2065731478.USD","LU1878469433.USD"],"gpt_icon":0},{"id":"2528209232","title":"瑞穗银行:维持Glaukos(GKOS.US)评级,由优于大市调整至优于大市评级, 目标价由200.00美元调整至175.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2528209232","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528209232?lang=zh_cn&edition=full","pubTime":"2025-04-17 01:24","pubTimestamp":1744824249,"startTime":"0","endTime":"0","summary":"瑞穗银行:维持Glaukos(GKOS.US)评级,由优于大市调整至优于大市评级, 目标价由200.00美元调整至175.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/17012449603803.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["161121","GKOS"],"gpt_icon":0},{"id":"2527244363","title":"Glaukos Corporation盘中异动 股价大跌5.85%报89.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527244363","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527244363?lang=zh_cn&edition=full","pubTime":"2025-04-16 21:50","pubTimestamp":1744811433,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日21时50分,Glaukos Corporation股票出现波动,股价快速跳水5.85%。截至发稿,该股报89.00美元/股,成交量10.3042万股,换手率0.18%,振幅3.76%。Glaukos Corporation股票所在的医疗器械行业中,整体涨幅为0.64%。Glaukos Corporation公司简介:Glaukos Corp是一家眼科制药和医疗技术公司,专注于开发用于青光眼、角膜疾病和视网膜疾病治疗的新型、无滴疗法和商业化相关产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416215033aa2c7177&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416215033aa2c7177&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065731478.USD","IE0009354923.USD","LU1878469433.USD","BK4082","BK4548","GKOS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.glaukos.com","stockEarnings":[{"period":"1week","weight":0.003},{"period":"1month","weight":0.047},{"period":"3month","weight":0.1525},{"period":"6month","weight":-0.3368},{"period":"1year","weight":-0.1577},{"period":"ytd","weight":-0.3077}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Glaukos Corporation于1998年7月14日在特拉华州注册成立。该公司是一家眼科制药和医疗技术公司,专注于开发新型无滴剂疗法,并将相关产品商业化,用于治疗青光眼、角膜疾病和视网膜疾病。他们首先开发了微创青光眼手术(MIGS)作为传统青光眼治疗模式的替代方案,并于2012年推出了他们的第一台MIGS设备。他们还提供商业化的专有生物激活药物疗法,用于治疗罕见的角膜疾病圆锥角膜,该疗法于2016年获得美国食品和药物管理局(FDA)的批准。他们正在开发一系列平台,以支持正在进行的制药和医疗器械创新。","yearOnYearQuotes":[{"month":1,"riseRate":0.9,"avgChangeRate":0.086384},{"month":2,"riseRate":0.6,"avgChangeRate":-0.00698},{"month":3,"riseRate":0.6,"avgChangeRate":-0.022683},{"month":4,"riseRate":0.5,"avgChangeRate":0.010953},{"month":5,"riseRate":0.6,"avgChangeRate":0.024636},{"month":6,"riseRate":0.9,"avgChangeRate":0.110675},{"month":7,"riseRate":0.727273,"avgChangeRate":0.034044},{"month":8,"riseRate":0.4,"avgChangeRate":0.042947},{"month":9,"riseRate":0.4,"avgChangeRate":-0.020194},{"month":10,"riseRate":0.5,"avgChangeRate":-0.024992},{"month":11,"riseRate":0.5,"avgChangeRate":0.012839},{"month":12,"riseRate":0.5,"avgChangeRate":0.008639}],"exchange":"NYSE","name":"Glaukos Corp","nameEN":"Glaukos"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Glaukos Corp(GKOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Glaukos Corp(GKOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Glaukos Corp,GKOS,Glaukos Corp股票,Glaukos Corp股票老虎,Glaukos Corp股票老虎国际,Glaukos Corp行情,Glaukos Corp股票行情,Glaukos Corp股价,Glaukos Corp股市,Glaukos Corp股票价格,Glaukos Corp股票交易,Glaukos Corp股票购买,Glaukos Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Glaukos Corp(GKOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Glaukos Corp(GKOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}